GSK wins FDA approval for Blujepa, a new oral antibiotic treatment option for uncomplicated urogenital gonorrhea.

The best PFS results we’ve ever seen in relapsed, refractory myeloma.”The combination of teclistamab (Tecvayli, Janssen) plus ...

Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific ...

T cell therapy anitocabtagene autoleucel (anito-cel) continued to show strong results in treating relapsed/refractory ...

GSK and Ideaya first linked up in 2020 to advance novel therapies for solid tumors. It is unclear why the pharma terminated ...

The company's BCMAxCD3 bispecific antibody Lynozyfic (linvoseltamab) got its first FDA approval as a fifth-line or later ...

(GLOBE NEWSWIRE) -- "Relapsed/Refractory Multiple Myeloma (RRMM) is difficult to manage because there's no clear, consistent guidance -- ask five academic physicians and you'll get five different ...

When Ralph Markham and Cathy Campbell were teenagers, there was a dividing line between the East and West sides of their city ...

Tens of thousands of NHS patients are set to benefit from a landmark trade agreement between the UK and the US that will ...

Melbourne man Ralph Markham’s life was transformed by love and, later, a devastating cancer diagnosis. Now, he is hoping new ...